These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25241302)

  • 21. Effectiveness of repeat angiographic assessment in patients designated for radioembolization using yttrium-90 microspheres with initial extrahepatic accumulation of technitium-99m macroaggregated albumin: a single center's experience.
    Dudeck O; Wilhelmsen S; Ulrich G; Löwenthal D; Pech M; Amthauer H; Ricke J
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1083-93. PubMed ID: 21833803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Intra-arterial Complications of Planning and Treatment Angiograms for Y-90 Radioembolization.
    Ahmed O; Patel MV; Masrani A; Chong B; Osman M; Tasse J; Soni J; Turba UC; Arslan B
    Cardiovasc Intervent Radiol; 2017 May; 40(5):704-711. PubMed ID: 28078375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing standard pushable coils with fibered interlock detachable coils.
    Dudeck O; Bulla K; Wieners G; Ruehl R; Ulrich G; Amthauer H; Ricke J; Pech M
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):74-80. PubMed ID: 20390272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
    Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.
    Meyer C; Pieper CC; Ezziddin S; Wilhelm KE; Schild HH; Ahmadzadehfar H
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):231-7. PubMed ID: 24030669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries.
    Kao YH; Tan AE; Khoo LS; Lo RH; Chow PK; Goh AS
    Ann Nucl Med; 2011 Jun; 25(5):365-9. PubMed ID: 21234723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
    Theysohn JM; Ruhlmann M; Müller S; Dechene A; Best J; Haubold J; Umutlu L; Gerken G; Bockisch A; Lauenstein TC
    PLoS One; 2015; 10(9):e0137587. PubMed ID: 26335790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Same-day
    Gabr A; Kallini JR; Gates VL; Hickey R; Kulik L; Desai K; Thornburg B; Marshall K; Salzig K; Williams M; Del Castillo C; Ganger D; Hohlastos E; Baker T; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2353-2359. PubMed ID: 27315059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of Radioembolization with (90)Yttrium Resin Microspheres Depending on Coiling or No-Coiling of Aberrant/High-Risk Vessels.
    Paprottka PM; Paprottka KJ; Walter A; Haug AR; Trumm CG; Lehner S; Fendler WP; Jakobs TF; Reiser MF; Zech CJ
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):946-56. PubMed ID: 25986465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of transarterial radioembolization with Yttrium-90 glass microspheres without cystic artery occlusion.
    Topcuoglu OM; Alan Selcuk N; Sarikaya B; Toklu T
    Radiol Med; 2019 Jun; 124(6):575-580. PubMed ID: 30635753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
    McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
    J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis.
    Chao C; Stavropoulos SW; Mondschein JI; Dagli M; Sudheendra D; Nadolski G; Soulen MC
    Clin Nucl Med; 2017 Mar; 42(3):176-179. PubMed ID: 28072623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization.
    Abdelmaksoud MH; Hwang GL; Louie JD; Kothary N; Hofmann LV; Kuo WT; Hovsepian DM; Sze DY
    J Vasc Interv Radiol; 2010 Sep; 21(9):1385-95. PubMed ID: 20688531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors.
    Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC
    Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Yttrium-90 Dose Conformality Using Proximal Radioembolization Enabled by Distal Angiosomal Truncation for the Treatment of Hepatic Malignancy.
    Core JM; Frey GT; Sharma A; Bussone ST; Legout JD; McKinney JM; Lewis AR; Ritchie C; Devcic Z; Paz-Fumagalli R; Toskich BB
    J Vasc Interv Radiol; 2020 Jun; 31(6):934-942. PubMed ID: 32381352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study.
    Pasciak AS; McElmurray JH; Bourgeois AC; Heidel RE; Bradley YC
    J Vasc Interv Radiol; 2015 May; 26(5):660-9. PubMed ID: 25801854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Aug; 17(8):1251-78. PubMed ID: 16923973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.